Immunodetection of 11 beta-hydroxysteroid dehydrogenase type 2 in human mineralocorticoid target tissues: Evidence for nuclear localization

被引:84
|
作者
Shimojo, M
Ricketts, ML
Petrelli, MD
Moradi, P
Johnson, GD
Bradwell, AR
Hewison, M
Howie, AJ
Stewart, PM
机构
[1] UNIV BIRMINGHAM, QUEEN ELIZABETH HOSP, DEPT MED, BIRMINGHAM B15 2TH, W MIDLANDS, ENGLAND
[2] UNIV BIRMINGHAM, QUEEN ELIZABETH HOSP, DEPT PATHOL, BIRMINGHAM B15 2TH, W MIDLANDS, ENGLAND
关键词
D O I
10.1210/en.138.3.1305
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
11 beta-Hydroxysteroid dehydrogenase (11 beta HSD) is an enzyme complex responsible for the conversion of hormonally active cortisol to inactive cortisone; two isoforms of the enzyme have been cloned and characterized. Clinical observations from patients with the hypertensive syndrome apparent mineralocorticoid excess, recently explained on the basis of mutations in the human 11 beta HSD2 gene, suggest that it is the 11 beta HSD2 isoform that serves a vital role in dictating specificity upon the mineralocorticoid receptor (MR). We have raised a novel antibody in sheep against human 11 beta HSD2 using synthetic multiantigenic peptides and have examined the localization and subcellular distribution of 11 beta HSD2 in mineralocorticoid target tissues. The immunopurified antibody recognized a single band of approximately 44 kDa in placenta, trophoblast, and distal colon. In kidney tissue, two bands of approximately 44 and 48 kDa were consistently observed. No signal was seen in decidua, adrenal, or liver. Immunoperoxidase studies on the mineralocorticoid target tissues, kidney, colon, and parotid gland indicated positive staining in epithelial cells known to express the MR: respectively, renal collecting ducts, surface and crypt colonic epithelial cells, and parotid duct epithelial cells. No staining was seen in these tissues in other sites. The intracellular localization of 11 beta HSD2 in kidney and colon epithelial cells was addressed using confocal laser microscopy. Parallel measurements of 11 beta HSD2 and nuclear propidium iodide fluorescence on sections scanned through an optical section of approximately 0.1 mu m indicated significant 11 beta HSD2 immunofluorescence in the nucleus. In human kidney, colon, and salivary gland, 11 beta HSD2 protects the MR from glucocorticoid excess in an autocrine fashion. Furthermore, within these tissues, 11 beta HSD2, which had been considered to be a microsomal enzyme, is also found in the nucleus, suggesting that the interaction between the MR and aldosterone or cortisol is in part a nuclear event.
引用
收藏
页码:1305 / 1311
页数:7
相关论文
共 50 条
  • [41] Immunochemical distribution and immunohistochemical localization of 20 beta-hydroxysteroid dehydrogenase in neonatal pig tissues
    Kobayashi, K
    Ohno, S
    Shinoda, M
    Toyoshima, S
    Nakajin, S
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1996, 59 (5-6): : 485 - 493
  • [42] Evidence for isoforms of 11 beta-hydroxysteroid dehydrogenase in the liver and kidney of the guinea pig
    Quinkler, M
    Kosmale, B
    Bahr, V
    Oelkers, W
    Diederich, S
    JOURNAL OF ENDOCRINOLOGY, 1997, 153 (02) : 291 - 298
  • [43] Immunocytochemical localization of type I 17 beta-hydroxysteroid dehydrogenase in the rat brain
    Pelletier, G
    LuuThe, V
    Labrie, F
    BRAIN RESEARCH, 1995, 704 (02) : 233 - 239
  • [44] DEVELOPMENT OF ACTIVITY OF 3 BETA-HYDROXYSTEROID DEHYDROGENASE IN HUMAN FETAL TISSUES AND IN 2 ANENCEPHALIC NEWBORNS
    GOLDMAN, AS
    YAKOVAC, WC
    BONGIOVANNI, AM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1966, 26 (01): : 14 - +
  • [45] Type II 11 beta-hydroxysteroid dehydrogenase (11BHSD2) expression and activity in the human adrenal cortex (ADC)
    Mazzocchi, G
    Rossi, GP
    Neri, G
    Malendowicz, LK
    Albertin, G
    Nussdorfer, GG
    JOURNAL OF HYPERTENSION, 1998, 16 : S59 - S59
  • [46] Inactivation of 11 beta-hydroxysteroid dehydrogenase type 1 by gene targeting in mice
    Kotelevtsev, YV
    Jamieson, PM
    Best, R
    Stewart, F
    Edwards, CRW
    Seckl, JR
    Mullins, JJ
    ENDOCRINE RESEARCH, 1996, 22 (04) : 791 - 792
  • [47] Metyrapone is a competitive inhibitor of 11 beta-hydroxysteroid dehydrogenase type 1 reductase
    SampathKumar, R
    Yu, M
    Khalil, MW
    Yang, K
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1997, 62 (2-3): : 195 - 199
  • [48] N-glycosylation is not essential for enzyme activity of 11 beta-hydroxysteroid dehydrogenase type 2
    Kyossev, ZN
    Reeves, WB
    KIDNEY INTERNATIONAL, 1997, 52 (03) : 682 - 686
  • [49] Cloning and expression of the 11 beta-hydroxysteroid dehydrogenase type 1 gene in the baboon
    Davies, WA
    Luo, H
    Dong, KW
    Albrecht, ED
    Pepe, GJ
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1997, 127 (02) : 201 - 209
  • [50] 11β-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human placenta
    Hirasawa, G
    Takeyama, J
    Sasano, H
    Fukushima, K
    Suzuki, T
    Muramatu, Y
    Darnel, AD
    Kaneko, C
    Hiwatashi, N
    Toyota, T
    Nagura, H
    Krozowski, ZS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03): : 1306 - 1309